Antiplasmodial Activity and Toxicological Assessment of Curcumin PLGA-Encapsulated Nanoparticles

Curcumin is a polyphenolic pigment isolated from the rhizomes of Curcuma longa (turmeric), a medicinal plant widely used in the ancient Indian and Chinese medicine. The antiplasmodial activity of curcumin is often hampered by its fast metabolism and poor water solubility, thus its incorporation into...

Full description

Bibliographic Details
Main Authors: Zulaikha A. Busari, Kabiru A. Dauda, Olajumoke A. Morenikeji, Funmilayo Afolayan, Oyetunde T. Oyeyemi, Jairam Meena, Debasis Sahu, Amulya K. Panda
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00622/full
_version_ 1811339062015950848
author Zulaikha A. Busari
Kabiru A. Dauda
Olajumoke A. Morenikeji
Funmilayo Afolayan
Oyetunde T. Oyeyemi
Oyetunde T. Oyeyemi
Jairam Meena
Debasis Sahu
Debasis Sahu
Amulya K. Panda
author_facet Zulaikha A. Busari
Kabiru A. Dauda
Olajumoke A. Morenikeji
Funmilayo Afolayan
Oyetunde T. Oyeyemi
Oyetunde T. Oyeyemi
Jairam Meena
Debasis Sahu
Debasis Sahu
Amulya K. Panda
author_sort Zulaikha A. Busari
collection DOAJ
description Curcumin is a polyphenolic pigment isolated from the rhizomes of Curcuma longa (turmeric), a medicinal plant widely used in the ancient Indian and Chinese medicine. The antiplasmodial activity of curcumin is often hampered by its fast metabolism and poor water solubility, thus its incorporation into a delivery system could circumvent this problem. This study aimed to evaluate the in vivo antiplasmodial activity and the toxicity assessment of curcumin incorporated into poly (lactic-co-glycolic) acid (PLGA) nanoparticles. Curcumin was loaded with poly (D,L-lactic-co-glycolic acid) (PLGA) using solvent evaporation from oil-in-water single emulsion method. The nanoparticles were characterized and evaluated in vivo for antimalarial activities using Peter’s 4-day suppressive protocol in mice model. Hematological and hepatic toxicity assays were performed on whole blood and plasma, respectively. In vivo anti-parasitic test and toxicity assays for free and encapsulated drug were performed at 5 and 10 mg/kg. In vitro cytotoxicity of free and PLGA encapsulated curcumin (Cur-PLGA) to RAW 264.7 cell line was also determined at varying concentrations (1000–7.8 μg/mL). The size and entrapment efficiency of the nanoparticulate drug formulated was 291.2 ± 82.1 nm and 21.8 ± 0.4 respectively. The percentage parasite suppression (56.8%) at 5 mg/kg was significantly higher than in free drug (40.5%) of similar concentration (p < 0.05) but not at 10 mg/kg (49.5%) at 4-day post-treatment. There were no significant differences in most of the recorded blood parameters in free curcumin and PLGA encapsulated nanoparticulate form (p > 0.05) except in lymphocytes which were significantly higher in Cur-PLGA compared to the free drug (p < 0.05). There were no significant differences in hepatotoxic biomarkers; aspartate aminotransferase and alanine aminotransferase concentrations in various treatment groups (p > 0.05). At higher concentrations (1000 and 500 μg/mL), Cur-PLGA entrapped nanoparticle showed higher toxicity compared with the free drug (p < 0.05) in exposed RAW 264.7 cell line. The cell viability was, however, higher in Cur-PLGA nanoparticles than in free curcumin at lower concentrations (p > 0.05). The antiplasmodial activity and safety of Cur-PLGA was better at lower concentration.
first_indexed 2024-04-13T18:20:30Z
format Article
id doaj.art-3c3d7baaa7054b5b9b852c3ae49a467a
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-13T18:20:30Z
publishDate 2017-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-3c3d7baaa7054b5b9b852c3ae49a467a2022-12-22T02:35:28ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122017-09-01810.3389/fphar.2017.00622225923Antiplasmodial Activity and Toxicological Assessment of Curcumin PLGA-Encapsulated NanoparticlesZulaikha A. Busari0Kabiru A. Dauda1Olajumoke A. Morenikeji2Funmilayo Afolayan3Oyetunde T. Oyeyemi4Oyetunde T. Oyeyemi5Jairam Meena6Debasis Sahu7Debasis Sahu8Amulya K. Panda9Department of Zoology, University of IbadanIbadan, NigeriaDepartment of Zoology, University of IbadanIbadan, NigeriaDepartment of Zoology, University of IbadanIbadan, NigeriaDepartment of Zoology, University of IbadanIbadan, NigeriaDepartment of Biological Sciences, University of Medical SciencesOndo, NigeriaProduct Development Cell, National Institute of ImmunologyNew Delhi, IndiaProduct Development Cell, National Institute of ImmunologyNew Delhi, IndiaProduct Development Cell, National Institute of ImmunologyNew Delhi, IndiaDepartment of Biochemistry, School of Bioengineering and Biosciences, Lovely Professional UniversityPhagwara, IndiaProduct Development Cell, National Institute of ImmunologyNew Delhi, IndiaCurcumin is a polyphenolic pigment isolated from the rhizomes of Curcuma longa (turmeric), a medicinal plant widely used in the ancient Indian and Chinese medicine. The antiplasmodial activity of curcumin is often hampered by its fast metabolism and poor water solubility, thus its incorporation into a delivery system could circumvent this problem. This study aimed to evaluate the in vivo antiplasmodial activity and the toxicity assessment of curcumin incorporated into poly (lactic-co-glycolic) acid (PLGA) nanoparticles. Curcumin was loaded with poly (D,L-lactic-co-glycolic acid) (PLGA) using solvent evaporation from oil-in-water single emulsion method. The nanoparticles were characterized and evaluated in vivo for antimalarial activities using Peter’s 4-day suppressive protocol in mice model. Hematological and hepatic toxicity assays were performed on whole blood and plasma, respectively. In vivo anti-parasitic test and toxicity assays for free and encapsulated drug were performed at 5 and 10 mg/kg. In vitro cytotoxicity of free and PLGA encapsulated curcumin (Cur-PLGA) to RAW 264.7 cell line was also determined at varying concentrations (1000–7.8 μg/mL). The size and entrapment efficiency of the nanoparticulate drug formulated was 291.2 ± 82.1 nm and 21.8 ± 0.4 respectively. The percentage parasite suppression (56.8%) at 5 mg/kg was significantly higher than in free drug (40.5%) of similar concentration (p < 0.05) but not at 10 mg/kg (49.5%) at 4-day post-treatment. There were no significant differences in most of the recorded blood parameters in free curcumin and PLGA encapsulated nanoparticulate form (p > 0.05) except in lymphocytes which were significantly higher in Cur-PLGA compared to the free drug (p < 0.05). There were no significant differences in hepatotoxic biomarkers; aspartate aminotransferase and alanine aminotransferase concentrations in various treatment groups (p > 0.05). At higher concentrations (1000 and 500 μg/mL), Cur-PLGA entrapped nanoparticle showed higher toxicity compared with the free drug (p < 0.05) in exposed RAW 264.7 cell line. The cell viability was, however, higher in Cur-PLGA nanoparticles than in free curcumin at lower concentrations (p > 0.05). The antiplasmodial activity and safety of Cur-PLGA was better at lower concentration.http://journal.frontiersin.org/article/10.3389/fphar.2017.00622/fullpolymeric nanoparticlescurcuminantimalarialsafety
spellingShingle Zulaikha A. Busari
Kabiru A. Dauda
Olajumoke A. Morenikeji
Funmilayo Afolayan
Oyetunde T. Oyeyemi
Oyetunde T. Oyeyemi
Jairam Meena
Debasis Sahu
Debasis Sahu
Amulya K. Panda
Antiplasmodial Activity and Toxicological Assessment of Curcumin PLGA-Encapsulated Nanoparticles
Frontiers in Pharmacology
polymeric nanoparticles
curcumin
antimalarial
safety
title Antiplasmodial Activity and Toxicological Assessment of Curcumin PLGA-Encapsulated Nanoparticles
title_full Antiplasmodial Activity and Toxicological Assessment of Curcumin PLGA-Encapsulated Nanoparticles
title_fullStr Antiplasmodial Activity and Toxicological Assessment of Curcumin PLGA-Encapsulated Nanoparticles
title_full_unstemmed Antiplasmodial Activity and Toxicological Assessment of Curcumin PLGA-Encapsulated Nanoparticles
title_short Antiplasmodial Activity and Toxicological Assessment of Curcumin PLGA-Encapsulated Nanoparticles
title_sort antiplasmodial activity and toxicological assessment of curcumin plga encapsulated nanoparticles
topic polymeric nanoparticles
curcumin
antimalarial
safety
url http://journal.frontiersin.org/article/10.3389/fphar.2017.00622/full
work_keys_str_mv AT zulaikhaabusari antiplasmodialactivityandtoxicologicalassessmentofcurcuminplgaencapsulatednanoparticles
AT kabiruadauda antiplasmodialactivityandtoxicologicalassessmentofcurcuminplgaencapsulatednanoparticles
AT olajumokeamorenikeji antiplasmodialactivityandtoxicologicalassessmentofcurcuminplgaencapsulatednanoparticles
AT funmilayoafolayan antiplasmodialactivityandtoxicologicalassessmentofcurcuminplgaencapsulatednanoparticles
AT oyetundetoyeyemi antiplasmodialactivityandtoxicologicalassessmentofcurcuminplgaencapsulatednanoparticles
AT oyetundetoyeyemi antiplasmodialactivityandtoxicologicalassessmentofcurcuminplgaencapsulatednanoparticles
AT jairammeena antiplasmodialactivityandtoxicologicalassessmentofcurcuminplgaencapsulatednanoparticles
AT debasissahu antiplasmodialactivityandtoxicologicalassessmentofcurcuminplgaencapsulatednanoparticles
AT debasissahu antiplasmodialactivityandtoxicologicalassessmentofcurcuminplgaencapsulatednanoparticles
AT amulyakpanda antiplasmodialactivityandtoxicologicalassessmentofcurcuminplgaencapsulatednanoparticles